Israel relaxes restrictions on medical marijuana; scientists develop new HIV/AIDS treatment

7 September 2010

Israel's Ministry of Health has authorized doctors from five of the country's different hospitals to prescribe medical marijuana to patients suffering from cancer and chronic pain, reports the local Haaretz.com. According to a Ministry official quoted by the newspaper, in future, department managers in the Kupot Holim, the Israeli health maintenance organizations, will be able to prescribe medical marijuana to patients.

Most prescriptions for medical marijuana are given to patients suffering from chronic pain, including patients with fibromyalgia, cancer, HIV/AIDS, neurological disorders, multiple sclerosis, asthma and glaucoma, as well as to Israel Defense Forces veterans suffering from post-traumatic stress disorder.

Until now, 14 Israeli farms have been given permits to grow marijuana legally for medicinal use, but only three are currently operating. The Health Ministry recently approved a monthly fee of 360 new Israeli shekels ($95.26) per medical marijuana user to cover growing expenses.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical